David Shulman, MD
Dr. David Shulman studies novel therapies and biomarkers for advanced pediatric solid tumors within the Dana-Farber Experimental Therapeutics Program. In addition to early phase clinical trials, Dr. Shulman also studies...
Dr. David Shulman studies novel therapies and biomarkers for advanced pediatric solid tumors within the Dana-Farber Experimental Therapeutics Program. In addition to early phase clinical trials, Dr. Shulman also studies...
Dr. Takahashi completed Pediatric Residency at SUNY Downstate Medical Center, and he then Pediatric Hematology/Oncology fellowship at the University of Minnesota, where he also completed PhD in Experimental and Clinical...
Dr. Sue Morris is a senior psychologist and Director of Bereavement Services at Dana-Farber Cancer Institute in Boston. She is also a member of Robert's Program on Sudden Unexpected Death...
Dr. Leslie Lehmann is the clinical director of the Stem Cell Transplantation Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. She specializes in bone marrow and stem cell transplantation...
I am an attending pediatric oncologist and physician scientist interested in the discovery and design of new therapeutic agents for pediatric cancers.